The Science of Aging and Where Supplements Fit
Aging research has advanced dramatically in the past two decades. Scientists have identified several hallmarks of aging including genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, mitochondrial dysfunction, cellular senescence, and altered nutrient sensing. These hallmarks interact and amplify each other, creating the cascade of decline we recognize as aging.
Longevity supplements aim to intervene in one or more of these pathways. The field gained enormous public attention through the work of researchers like David Sinclair at Harvard, whose research on NAD+ precursors and sirtuins has driven consumer interest in compounds like NMN and resveratrol. However, it is essential to separate what the science actually shows in human trials from what has only been demonstrated in mice, worms, or cell cultures.
The honest reality is that no supplement has been proven to extend human lifespan in a randomized controlled trial. What we have instead are compounds that improve biomarkers associated with aging, show lifespan extension in animal models, and demonstrate mechanisms of action that are plausible for human benefit. This guide evaluates the leading candidates with that important caveat in mind.
NMN and NR: Boosting NAD+ for Cellular Energy
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme present in every living cell, essential for energy metabolism, DNA repair, and sirtuin activation. NAD+ levels decline by approximately 50% between ages 40 and 60, and this decline is implicated in multiple age-related diseases. Two precursor supplements can raise NAD+ levels: nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR).
NMN gained prominence through the work of David Sinclair, who demonstrated dramatic health improvements in aged mice supplemented with NMN, including restored muscle function, improved insulin sensitivity, and enhanced blood flow. A 2022 randomized, double-blind, placebo-controlled trial by Yi et al. in Science showed that 12 weeks of NMN supplementation (250 mg/day) improved muscle insulin sensitivity and muscle remodeling in prediabetic postmenopausal women. A 2024 study by Katayoshi et al. confirmed that NMN at 250 mg/day significantly increased blood NAD+ levels in healthy adults.
NR (as Niagen) has a longer track record of human trials. Martens et al. (2018) published in Nature Communications showed that NR at 1,000 mg/day for six weeks raised NAD+ by approximately 60% in healthy middle-aged and older adults and showed trends toward reduced systemic blood pressure and arterial stiffness. A 2023 trial by Remie et al. confirmed NAD+ elevation but found limited effects on metabolic outcomes in obese adults, highlighting that raised NAD+ does not automatically translate to clinical improvements.
| Compound | Human NAD+ Increase | Typical Dose | Key Trial Findings |
|---|---|---|---|
| NMN | 40-80% increase | 250-500 mg/day | Improved insulin sensitivity, increased NAD+ |
| NR | 40-90% increase | 300-1,000 mg/day | Raised NAD+, trends in blood pressure reduction |
The effective dose for NMN in human studies ranges from 250 to 500 mg daily, while NR studies typically use 300 to 1,000 mg daily. Both compounds are well tolerated in trials up to 12 weeks, though long-term safety data beyond one year remains limited.
Resveratrol: Promise and Controversy
Resveratrol is a polyphenol found in red grape skins, red wine, and Japanese knotweed. It gained fame through early research showing it activated SIRT1, a sirtuin protein associated with caloric restriction benefits and lifespan extension. Sinclair's 2006 Nature paper showed resveratrol extended lifespan in obese mice fed a high-fat diet and improved their metabolic health.
However, the resveratrol story has become more complicated with subsequent research. A major issue is bioavailability: resveratrol is rapidly metabolized in the human gut and liver, resulting in very low circulating levels of the active compound after oral dosing. Walle et al. (2004) demonstrated that despite near-complete absorption, the oral bioavailability of unmodified resveratrol is less than 1%.
Human clinical evidence is mixed. A 2015 meta-analysis by Hausenblas et al. found that resveratrol improved glycemic control in diabetic patients but had no significant effect in non-diabetic subjects. Timmers et al. (2011) showed that 150 mg/day of resveratrol for 30 days mimicked some effects of caloric restriction in obese men, including reduced inflammation and improved mitochondrial function. However, a well-designed 2014 study by Semba et al. published in JAMA Internal Medicine followed 783 older adults in Italy and found that urinary resveratrol metabolites (from dietary intake) were not associated with longevity, cardiovascular disease, or cancer outcomes.
Current evidence suggests resveratrol may have modest metabolic benefits at doses of 150 to 500 mg daily, particularly in combination with other compounds. Sinclair himself takes resveratrol with a fat source to enhance absorption, combined with NMN. However, the evidence does not support resveratrol as a standalone longevity intervention.
CoQ10: Mitochondrial Powerhouse
Coenzyme Q10 (CoQ10), also known as ubiquinone, is a naturally occurring compound in the mitochondrial electron transport chain that is essential for ATP production. CoQ10 levels decline with age and are further depleted by statin medications, which block the same biosynthetic pathway used to produce CoQ10.
The most compelling human longevity-relevant evidence for CoQ10 comes from the Q-SYMBIO trial, a randomized, double-blind study of 420 patients with heart failure published by Mortensen et al. (2014) in JACC: Heart Failure. After two years of CoQ10 supplementation (300 mg/day), the treatment group had a 43% reduction in cardiovascular mortality compared to placebo. This was one of the first supplement trials to demonstrate a significant reduction in hard clinical endpoints.
For healthy aging, CoQ10 functions as both a mitochondrial cofactor and a potent lipid-soluble antioxidant. A 2018 randomized trial by Testai et al. showed that 200 mg/day of CoQ10 for 12 weeks improved endothelial function and reduced oxidative stress markers in healthy older adults. The ubiquinol form (reduced CoQ10) has approximately two to three times better bioavailability than the ubiquinone form.
Standard dosing is 100 to 300 mg daily of ubiquinol, taken with a fat-containing meal for optimal absorption. CoQ10 is particularly important for individuals taking statins, who may experience up to a 40% reduction in circulating CoQ10 levels.
Emerging Longevity Compounds: Spermidine and Fisetin
Two newer compounds are generating significant interest in the longevity research community: spermidine and fisetin.
Spermidine is a polyamine found in wheat germ, aged cheese, mushrooms, and soybeans. It induces autophagy, the cellular recycling process that declines with age and is considered one of the key mechanisms behind the benefits of caloric restriction and fasting. Eisenberg et al. (2016) published in Nature Medicine showed that spermidine extended lifespan in yeast, flies, worms, and mice, and reduced cardiac aging in mice. A 2018 epidemiological study by Kiechl et al. in the American Journal of Clinical Nutrition followed 829 participants for 20 years and found that higher dietary spermidine intake was associated with significantly reduced all-cause mortality. A small 2022 human trial showed that 1.2 mg/day of plant-derived spermidine improved memory performance in older adults at risk of dementia.
Fisetin is a flavonoid found in strawberries, apples, and persimmons that has emerged as a potent senolytic, meaning it selectively eliminates senescent ("zombie") cells that accumulate with age and drive inflammation. Yousefzadeh et al. (2018) published in EBioMedicine demonstrated that fisetin reduced senescent cell burden and extended lifespan in aged mice by approximately 10%, even when administered late in life. The Intervention Testing Program at the National Institute on Aging confirmed lifespan extension in a genetically heterogeneous mouse population.
Human trials of fisetin are underway. The Mayo Clinic is conducting clinical trials of fisetin as a senolytic agent in adults with age-related conditions. Preliminary results suggest it is well tolerated at doses of 100 mg to 500 mg daily, though efficacy data in humans is not yet published in peer-reviewed form.
Both spermidine and fisetin are in earlier stages of clinical development than NMN, NR, or CoQ10. They are promising but should be considered experimental from a supplement consumer perspective.
What David Sinclair Takes vs What Evidence Supports
David Sinclair has publicly shared his personal supplement regimen, which includes NMN (1 g/day), resveratrol (1 g/day with yogurt), metformin (800 mg/day, prescription), vitamin D, vitamin K2, and low-dose aspirin. This regimen has become influential in the longevity supplement community, but it is important to contextualize it.
Sinclair is a researcher who monitors his biomarkers regularly and has access to resources and medical supervision that most consumers do not. Several components of his stack are based on his own laboratory research, which may introduce optimism bias. Metformin for non-diabetics remains controversial, with the TAME (Targeting Aging with Metformin) trial still ongoing. His resveratrol dose (1 g/day) exceeds the doses used in most positive clinical trials, and the NMN dose (1 g/day) is two to four times higher than what has been studied in published human RCTs.
What the evidence more conservatively supports for general consumers is NMN or NR at 250-500 mg daily for NAD+ support, CoQ10 at 100-300 mg daily (especially for those over 50 or on statins), and foundational supplements like vitamin D and omega-3 fatty acids where deficiency is common. Resveratrol and spermidine are reasonable additions for those willing to accept that the human evidence is still emerging.
The Bigger Picture: Lifestyle First
No supplement can compensate for poor lifestyle habits when it comes to longevity. The most robust evidence for lifespan extension comes from caloric restriction, regular exercise, quality sleep, social connection, and stress management. The Blue Zones research, studying populations with the highest concentrations of centenarians, identifies diet, movement, purpose, and community as the primary drivers of exceptional longevity.
Supplements should be viewed as potential optimizers layered on top of these fundamentals. The compounds discussed in this guide target real biological mechanisms of aging, but the gap between promising mechanisms and proven human lifespan extension remains substantial. Approach longevity supplements with informed optimism tempered by scientific humility.